Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoreAge Rx vs MEDGm

CoreAge Rx
Site position #1

Higher grade

MEDGm
Site position #312

Lower grade

The verdict

CoreAge Rx takes it — 89.5/100 to 59.1/100.

CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.

CoreAge Rx scores 89.5/100 (B+).

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoreAge Rx +57
92
35
Dose & formulationCoreAge Rx +13
88
75
Clinical oversightCoreAge Rx +33
93
60
Labs & monitoringCoreAge Rx +39
90
51
FulfillmentCoreAge Rx +9
95
86
Contract termsEven
67
67
CoreAge Rx · top barMEDGm · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoreAge RxMEDGm
WeighScore89.5/10059.1/100
GradeB+C
Site position#1#312
Semaglutide$99/mo$299/mo (standing rate; $179 covers the first month only, after an auto-applied coupon)
Tirzepatide$149/mo$399/mo (standing rate; $279 covers the first month only)
CoverageAll 50 statesAll 50 states plus Washington, D.C.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedYes
CoreAge Rx

Site position #1 · B+

Strengths

  • Advertises the same medication price at every dose
  • Semaglutide and tirzepatide injection options
  • No membership fee; standard prescription shipping included unless checkout states otherwise

Where it loses points

  • Compounded only; no FDA-approved brand option listed
  • Dispensing pharmacy not identified on the reviewed product pages
  • Applicable $50–$100 consultation fee is nonrefundable after review begins
  • Orders become final after approval and pharmacy transmission; 30-day refund cutoff also applies
MEDGm

Site position #312 · C

Strengths

  • Names four dispensing pharmacies with street addresses and phone numbers
  • States its compounding class — produced in state-licensed 503A or FDA-registered facilities — rather than leaving it unsaid
  • Coverage is 50 states plus the District of Columbia and the intake's own state selector agrees with the Terms, which is rarer than it should be
  • Refills and shipping are described as included, with no separate shipping line at checkout
  • Prices an oral semaglutide lane alongside both injections

Where it loses points

  • No price is visible until a sixteen-screen quiz ending in name, email and phone number has been completed
  • $179 and $279 are first-month rates produced by an auto-applied coupon; the standing month-to-month rates are $299 and $399
  • The treatments FAQ says “your price never increases, even as your dose goes up” on a plan whose price increases at the first renewal
  • The twelve-month bundle auto-renews for another full upfront charge of $2,028 or $3,228, billed up to ten days early, and nothing is refundable once taken
  • The funnel prints “prescription plan approved” and a 100% success probability before any payment and before a clinician has seen the intake, beside a twenty-minute timer that resets on reload
  • Zepbound, Wegovy and Ozempic have cards on the GLP-1 page and all six links lead to the quiz; the post-intake funnel contains none of those names
  • No principal place of business is published — only a Delaware state of formation
  • No clinician is named and no NPI appears anywhere; the site names professional entities only

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard